---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-23-000078"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2023-04-14T23:59:59+00:00"
generated_at: "2026-06-17T01:46:13.628825+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lifecore Biomedical receives Nasdaq notice for late Q3 FY2023 10-Q filing

## Summary
- Nasdaq notified Lifecore on April 13, 2023 of non-compliance with Listing Rule 5250(c)(1) due to delayed Form 10-Q for period ended Feb 26, 2023.
- Company has 60 days (by June 12, 2023) to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant until October 10, 2023 to file the 10-Q.
- Notice has no immediate effect on trading of LFCR common stock; company intends to file promptly.
- This disclosure is required by Nasdaq Listing Rule 5810(b).

## SEC filing metadata
- accession: 0001005286-23-000078
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2023-04-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000078/0001005286-23-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000078/lndc-20230413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-23-000078
- JSON: https://secwatch.observer/filing/0001005286-23-000078.json
- Plain text: https://secwatch.observer/filing/0001005286-23-000078.txt

## Key facts
- Listing & Compliance Notices
  LIFECORE BIOMEDICAL, INC. DE received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: April 13, 2023, Lifecore Biomedical, Inc., a Delaware corporation (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended February 26, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The notification letter has no immediate
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000078/0001005286-23-000078-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.